Koff, Sondra  | Transaction

192,340원  | 20090630  | 9781412810425

Nonprofit organizations, their governing structures, boards of directors, and their newest constituency, members who represent the public at large, are the subject of this book. In recent years, new mechanisms have been developed to link citizens with government and with diverse policy-making entities. Earlier, it was assumed that citizens had little interest in policy deliberations, and responsibility for public needs was best left to the experts. Many citizens now believe that they have a legitimate right to influence how power is exercised in public organizations. Koff constructs a demographic profile of public members, their activities, and their opinions about board membership. She also catalogues the perspectives of executive directors about public members, identifies specific problems related to public participation, and suggests strategies to help resolve them. How effectively these bodies perform, and how well they respond to the public, are in part determined by the talents and activities of their members. All of these members, especially public members, need appropriate tools to be able to perform in a superior fashion. Despite the importance of governing bodies to an organization's performance, there has been little examination of board members in general and specifically of public members. This is the first book-length study on the subject.

Koff, Sondra Z.  | Routledge

89,740원  | 19991101  | 9780415196642

This book has been designed to provide readers with an up-to-date and accessible introduction to the complexities of Italian politics during the 1990s. It will equip readers with a sound understanding of the basics of Italian politics and governme...

Koff, Raymond S., Md. (Edt)/ Wu, George Y., Md, Ph  | Humana

0원  | 20010901  | 9780896038806

Leading scientists, clinicians, and clinical investigators comprehensively review the epidemiology, molecular virology, diagnosis, treatment, and prevention of chronic hepatitis caused by the B and C viruses. The discussion of patient management includes contributions on developing novel therapeutics, supporting patients during therapy, alternative treatments, the use of drugs in chronic viral hepatitis, liver transplantation, and pregnancy in chronic viral hepatitis. Attention is also given to the treatment of patients with concomitant autoimmune disorders, the management of HIV co-infection, and the management of HBV/HCV co-infection.